‘Cost of dying’ in UK hits record level as bereaved turn to crowdfunding to meet bills
Latest SunLife study shows average total funeral cost at £9,797 with many selling off possessions to help pay
Related Articles
Some Assembly Required
The IKEA effect and my new carOnce upon a time, when you bought a car, all you needed to know was where the gear shift…
Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial
Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
Cancer Prevalence across Vertebrates
Analysis of 16,049 animal necropsies from 292 vertebrate species shows that cancer prevalence increases with body mass and somatic mutation rates, but decreases with gestation…
A Queens woman trusted a ‘Star Sitter’ on Rover. Then her dog went missing.
She’s still looking for 3-month-old Phoebe, nearly two weeks after the dog reportedly disappeared in Kissena Corridor Park.
How I Treat Higher-Risk MDS
Myelodysplastic syndromes/neoplasms (MDS) are a widely heterogenous group of myeloid malignancies characterized by morphologic dysplasia, a defective hemat
Complexity of modern general practice has undermined quality, study finds
Measures introduced to support general practice – including greater use of remote consultations, digital triage and an expansion of additional roles – have had the…
Statement from Monica M. Bertagnolli, M.D., on ending her tenure as
Dr. Bertagnolli served as the 17th NIH Director.
